Acyldepsipeptide Antibiotics – Current State of Knowledge

Michał T. Pstrągowski, Magdalena Bujalska-Zadrożny
Pol J Microbiol
2015; 64 (2):
ICID: 1160937
Article type: Review article
IC™ Value: 8.00
Abstract provided by Publisher
 
The objective of this paper is to review and summarize the antimicrobial efficacy of the acyldepsipeptides and to indicate the prospects of the therapeutic values of these compounds. This work is enriched by the description of the mutations within the clpP1clpP2 and clpP3clpP4 operons of Streptomyces lividans, which are considered to be the potential mechanism of the acyldepsipeptide (ADEP) – resistance development. The researchers’ conclusions demonstrated a significant impact on microorganisms including the destabilization of bacterial cell division in Bacillus subtilis 168, Staphylococcus aureus HG001 and Streptococcus pneumoniae G9A strains. The results of animal studies show higher bactericidal effectiveness of the acyldepsipeptides ADEP-2 and ADEP-4 compared to linezolid. ADEPs may be considered as a very important mechanism of defense against the increasing resistance of microorganisms . They also might prevent or reduce the risk of many epidemiological events.
  FULL TEXT STATS


Related articles in IndexCopernicus™
     proteins Ftsz [0 related records]
     organization [4 related records]
     microtubule [1 related records]
     Hsp100 proteins [0 related records]
     Drug Resistance [639 related records]
     caseinolytic proteases A/X [0 related records]
     acyldepsipeptides [0 related records]